Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
Identifieur interne : 001560 ( PubMed/Checkpoint ); précédent : 001559; suivant : 001561Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
Auteurs : B J Snow [Canada] ; F J Vingerhoets ; J W Langston ; J W Tetrud ; V. Sossi ; D B CalneSource :
- Journal of neurology, neurosurgery, and psychiatry [ 0022-3050 ] ; 2000.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
- diagnostic imaging : Corpus Striatum, Parkinson Disease, Secondary.
- etiology : Parkinson Disease, Secondary.
- Adult, Female, Humans, Male, Middle Aged, Tomography, Emission-Computed.
Abstract
To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.
PubMed: 10675212
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:10675212Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.</title><author><name sortKey="Snow, B J" sort="Snow, B J" uniqKey="Snow B" first="B J" last="Snow">B J Snow</name><affiliation wicri:level="1"><nlm:affiliation>The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC, Canada. bsnow@ahsl.co.nz</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation></author><author><name sortKey="Vingerhoets, F J" sort="Vingerhoets, F J" uniqKey="Vingerhoets F" first="F J" last="Vingerhoets">F J Vingerhoets</name></author><author><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J W" last="Langston">J W Langston</name></author><author><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J W" last="Tetrud">J W Tetrud</name></author><author><name sortKey="Sossi, V" sort="Sossi, V" uniqKey="Sossi V" first="V" last="Sossi">V. Sossi</name></author><author><name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D B" last="Calne">D B Calne</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10675212</idno><idno type="pmid">10675212</idno><idno type="wicri:Area/PubMed/Corpus">001656</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001656</idno><idno type="wicri:Area/PubMed/Curation">001656</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001656</idno><idno type="wicri:Area/PubMed/Checkpoint">001656</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001656</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.</title><author><name sortKey="Snow, B J" sort="Snow, B J" uniqKey="Snow B" first="B J" last="Snow">B J Snow</name><affiliation wicri:level="1"><nlm:affiliation>The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC, Canada. bsnow@ahsl.co.nz</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation></author><author><name sortKey="Vingerhoets, F J" sort="Vingerhoets, F J" uniqKey="Vingerhoets F" first="F J" last="Vingerhoets">F J Vingerhoets</name></author><author><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J W" last="Langston">J W Langston</name></author><author><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J W" last="Tetrud">J W Tetrud</name></author><author><name sortKey="Sossi, V" sort="Sossi, V" uniqKey="Sossi V" first="V" last="Sossi">V. Sossi</name></author><author><name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D B" last="Calne">D B Calne</name></author></analytic><series><title level="j">Journal of neurology, neurosurgery, and psychiatry</title><idno type="ISSN">0022-3050</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)</term><term>Adult</term><term>Corpus Striatum (diagnostic imaging)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease, Secondary (diagnostic imaging)</term><term>Parkinson Disease, Secondary (etiology)</term><term>Tomography, Emission-Computed</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Corpus Striatum</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Tomography, Emission-Computed</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10675212</PMID><DateCreated><Year>2000</Year><Month>04</Month><Day>21</Day></DateCreated><DateCompleted><Year>2000</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3050</ISSN><JournalIssue CitedMedium="Print"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2000</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation></Journal><ArticleTitle>Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.</ArticleTitle><Pagination><MedlinePgn>313-6</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We scanned nine humans exposed to MPTP with parkinsonism ranging from minimal to severe using [(18)F]fluorodopa (FD) and high resolution PET. The results were compared with those of 10 patients with Parkinson's disease and six normal subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the MPTP group there was an equal degree of reduction of dopaminergic function in the caudate and putamen. This was different from the greater putaminal than caudate loss in Parkinson's disease (p<0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Parkinson's disease is not caused by transient exposure to MPTP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Snow</LastName><ForeName>B J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC, Canada. bsnow@ahsl.co.nz</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vingerhoets</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Langston</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Tetrud</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Sossi</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Calne</LastName><ForeName>D B</ForeName><Initials>DB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9P21XSP91P</RegistryNumber><NameOfSubstance UI="D015632">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1967 May;17(5):427-42</RefSource><PMID Version="1">6067254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 1979 Sep;43(1):59-82</RefSource><PMID Version="1">521829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1983 Feb 25;219(4587):979-80</RefSource><PMID Version="1">6823561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546-50</RefSource><PMID Version="1">6192438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Neurol Sci. 1984 Feb;11(1 Suppl):174-9</RefSource><PMID Version="1">6608982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1985 Sep 19-25;317(6034):246-8</RefSource><PMID Version="1">3876510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1988 Apr 7;318(14):876-80</RefSource><PMID Version="1">3352672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1988 Jan;24(1):161-74</RefSource><PMID Version="1">3259295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1988 Jul 28;334(6180):345-8</RefSource><PMID Version="1">2899295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1988 Oct 5;92(2):228-33</RefSource><PMID Version="1">3263594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1989 Oct;26(4):507-14</RefSource><PMID Version="1">2817827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1990 Feb;40(2):261-4</RefSource><PMID Version="1">2300245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1989;33(2):323-31</RefSource><PMID Version="1">2622529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1990 Apr 16;513(2):320-4</RefSource><PMID Version="1">2350702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1990 Oct;28(4):547-55</RefSource><PMID Version="1">2132742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1990 Sep 3;526(2):303-7</RefSource><PMID Version="1">2257487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1990 Oct 29;531(1-2):242-52</RefSource><PMID Version="1">1981162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1990 Nov 26;534(1-2):348-51</RefSource><PMID Version="1">2073599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 1991 Feb;114 ( Pt 1B):541-56</RefSource><PMID Version="1">1900728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Assist Tomogr. 1991 Jul-Aug;15(4):655-68</RefSource><PMID Version="1">2061484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1991 May;54(5):388-96</RefSource><PMID Version="1">1865199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1991;44(3):591-605</RefSource><PMID Version="1">1754053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 May 1;89(9):3859-63</RefSource><PMID Version="1">1570304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1992;32 Suppl:S88-93</RefSource><PMID Version="1">1510386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1992 May 29;581(2):283-91</RefSource><PMID Version="1">1382801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 1992 Aug 21;588(2):261-9</RefSource><PMID Version="1">1356591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Neurol. 1993;60:600-8</RefSource><PMID Version="1">8380528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1993 Mar;53(1):169-78</RefSource><PMID Version="1">8469305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucl Med. 1994 Jan;35(1):18-24</RefSource><PMID Version="1">8285951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):278-84</RefSource><PMID Version="1">8158173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1994 Jul 4;175(1-2):121-5</RefSource><PMID Version="1">7970192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1994 Nov;36(5):765-70</RefSource><PMID Version="1">7979223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1997 Jul;49(1):183-9</RefSource><PMID Version="1">9222188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phys Med Biol. 1994 Mar;39(3):411-24</RefSource><PMID Version="1">15551590</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):276</RefSource><PMID Version="1">10675207</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015632" MajorTopicYN="N">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010302" MajorTopicYN="N">Parkinson Disease, Secondary</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014055" MajorTopicYN="N">Tomography, Emission-Computed</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC1736814</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>2</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>4</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>2</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10675212</ArticleId><ArticleId IdType="pmc">PMC1736814</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Calne, D B" sort="Calne, D B" uniqKey="Calne D" first="D B" last="Calne">D B Calne</name><name sortKey="Langston, J W" sort="Langston, J W" uniqKey="Langston J" first="J W" last="Langston">J W Langston</name><name sortKey="Sossi, V" sort="Sossi, V" uniqKey="Sossi V" first="V" last="Sossi">V. Sossi</name><name sortKey="Tetrud, J W" sort="Tetrud, J W" uniqKey="Tetrud J" first="J W" last="Tetrud">J W Tetrud</name><name sortKey="Vingerhoets, F J" sort="Vingerhoets, F J" uniqKey="Vingerhoets F" first="F J" last="Vingerhoets">F J Vingerhoets</name></noCountry><country name="Canada"><noRegion><name sortKey="Snow, B J" sort="Snow, B J" uniqKey="Snow B" first="B J" last="Snow">B J Snow</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001560 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001560 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:10675212
|texte= Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:10675212" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |